Estrogen, cognition and female ageing

Human Reproduction Update

Volumn 13, Issue 2, 2007, Pages 175-187

  Genazzani, Andrea Riccardo ^a   Pluchino, Nicola ^a   Luisi, Stefano ^b   Luisi, Michele ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Ageing; CNS; Cognition; Estrogen; HRT

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; AMYLOID BETA PROTEIN; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MELATONIN; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROSTEROID; NEUROTRANSMITTER; PLACEBO;

AGING; ALZHEIMER DISEASE; BEHAVIOR; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM; CLIMACTERIUM; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; DEMENTIA; DRUG EFFICACY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; GENOME ANALYSIS; HUMAN; LIMBIC SYSTEM; MONOTHERAPY; MOOD; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OVARY CYCLE; PINEAL BODY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEASONAL VARIATION; SEX DIFFERENCE;

AGING; BRAIN; COGNITION; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 33847264525     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dml042     Document Type: Review

References (180)

1. Adams MM, Fink SE, Sha RA, Janssen WG, Hayashi S, Milner TA, McEwen BS and Morrison JH (2002) Estrogen and aging affect the subcellular distribution of estrogen receptor a in the hippocampus of female rats. J Neurosci 22,3608-3614.
2. Adler MW (1980) Minireview: Opioid peptides. Life Sci 26,496-510.
3. Akwa Y and Baulieu EE (1999) Neurosteroids: Behavioral aspects and physiological implications. J Soc Biol 193,293-298.
4. Aleem FA and McIntosh T (1985) Menopausal syndrome: Plasma levels of β-endorphin in postmenopausal women using a specific radioimmunoassay. Maturitas 13,76-84.
5. Alonso R, Abreu P and Fajardo N (1995) Ovarian hormones regulateα1- and β-adrenoceptor interactions in female rat pinealocytes. Neuroreport 6,345-348.
6. Alonso-Soleis R, Abreu P, Leopez-Coviella I, Hernandez G and Fajardo N (1996) Gonadal steroid modulation of neuroendocrine transduction: A transynaptic view. Cell Mol Neurobiol 3,357-382.
7. Ansonoff MA and Etgen AM (2000) Evidence that oestradiol attenuates beta-adrenoceptor function in the hypothalamus of female rats by altering receptor phosphorylation and sequestration. J Neuroendocrinol 12,1060-1066.
8. Arent J, Laud CA, Symons AM and Pryde SJ (1983) Plasma melatonin in ewes after ovariectomy. J Reprod Fertil 68,213-218.
9. Baldereschi M, DiCarlo A and Lepore V (1998) Estrogen replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 50,996-1002.
10. Baulieu EE (1991) Neurosteroids: A new function in the brain. Biol Cell 71,3-10.
11. Baulieu EE (1997) Neurosteroids: Of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52,1-32.
12. Baulieu EE, Robel P and Schumacher M (2001) Neurosteroids: Beginning of the story. Int Rev Neurobiol 46,1-32.
13. Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F (1999) FasL (CD95L, APO1L) is expressed in the normal rat and human brain evidence for the existence of an immunological brain barrier. Glia 27,62-74.
14. Behl C (2002) Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3,433-442.
15. Behl C and Holsboer F (1999) The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci 20,441-444.
16. Berman KF, Schmidt PJ, Rubinow DR, Danaceau MA, Van Horn JD, Esposito G, Ostrem JL and Weinberger DR (1997) Modulation of cognition-specific cortical activity by gonadal steroids: A positron-emission tomography study in women. Proc Natl Acad Sci USA 94,8836-8841.
17. Bernardi F, Lanzone A, Cento RM, Spada RS, Pezzani I, Genazzani AD, Luisi S, Luisi M, Petraglia F and Genazzani AR (2000) Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia. Eur J Endocrinol 142,466-471.
18. Bernardi F, Pieri M, Stomati M, Luisi S, Palumbo M, Pluchino N, Ceccarelli C and Genazzani AR (2003) Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol Endocrinol 17,65-77.
19. Beyer C (1999) Estrogen and the developing brain. Anat Embryol 199,379-390.
20. Beyer C, Pawlak J and Karolczak M (2003) Membrane receptors for oestrogen in the brain. J Neurochem 87,545-550.
21. Birau N, Peterssen U and Meyer C (1981) Gottschalk. Hypo-tensive effect of melatonin in essential hypertension. IRSC Med Sci 9,906.
22. Brinton RD (2001) Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: Recent insights and remaining challenges. Learn Mem 8,121-133.
23. Brinton RD, Tran J, Proffitt P and Montoya M (1997) 17 beta-Estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem Res 22,1339-1351.
24. Brinton RD, Chen S, Montoya M, Hsieh D and Minaya J (2000) The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. Maturitas 34,35-52.
25. Cagnacci A (1996) Melatonin in relation to physiology in adult humans. J Pineal Res 21,200-213.
26. Cagnacci A and Arangino S (2001) Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: Role of hormone replacement therapy. Clin Endocrinol 54,261-266.
27. Cagnacci A, Soldani R and Yen SSC (1997) Melatonin enhances cortisol levels in aged women: Reversible by estrogens. J Pineal Res 22,81-85.
28. Cagnacci A, Arangino S, Angiolucci M, Maschio E and Melis GB (1998) Influences of melatonin administration on the circulation of women. Am J Physiol 274,335-338.
29. Cardona-Gomez GP, Mendez P, DonCarlos LL, Azcoitia I and Garcia-Segura LM (2001) Interactions of estrogens and insulin-like growth factor-I in the brain: Implications for neuroprotection. Brain Res Brain Res Rev 37,320-334.
30. Carlson LE and Sherwin BB (1998) Steroid hormones, memory and mood in a healthy elderly population. Psychoneuroendocrinology 23,583-603.
31. Carlsson M and Carlsson A (1988) A regional study of sex differences in rat brain serotonin. Prog Neuropsychopharmacol Biol Psychiatry 12,53-61.
32. Chvatal A and Sykova E (2000) Glial influence on neuronal signaling. Prog Brain Res 125,199-216.
33. Clarke CH, Norfleet AM, Clarke MSF, Watson CS, Cunningham KA and Thomas ML (2000) Perimembrane localization of the estrogen receptor alpha protein in neuronal processes of cultured hippocampal neurons. Neuroendocrinology 71,34-42.
34. Cooke B, Hegstrom CD, Villeneuve LS and Breedlove SM (1998) Sexual differentiation of the vertebrate brain: Principles and mechanisms. Front Neuroendocrinol 19,323-362.
35. Couse JF, Lindzey J, Grandien K, Gustafsson JA and Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138,4613-4621.
36. Craft RM, Mogil JS and Aloisi AM (2004) Sex differences in pain and analgesia: The role of gonadal hormones. Eur J Pain 8,397-411.
37. Craig CM, Maki PM and Murphy D (2005) The Women's Health Initiative Memory Study: Findings and implications for treatment. Lancet Neurol4,190-194.
38. Decker MW (1987) The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res Rev 12,423-435.
39. Demling J, Fuchs E, Baumert W and Wuttke W (1985) Preoptic catecholamine, GABA, and glutamate release in ovariectomized and ovariectomized estrogen-primed rats utilizing a push-pull cannula technique. Neuroendocrinology 41,212-218.
40. Donouhe TL and Dorse DM (1982) The opiomelanotropinergic neuronal and endocrine system. Peptides 3,383-395.
41. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW and Wise PM (1998). Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18,1253-1258.
42. Eichenbaum H and Otto T (1992) The hippocampus - what does it do? Behav Neural Biol 57,2-36.
43. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R et al. (2004) Women's Health Initiative Memory Study conjugated equine estrogens and global cognitive function in postmenopausal women. Women's Health Initiative Memory Study. JAMA 291,2959-2968.
44. Etgen AM and Karkanias GB (1994) Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychoneuroendocrinology 19,603-610.
45. Falkenstein E and Wehling M (2000) Nongenomically initiated steroid actions. Eur J Clin Invest 30(Suppl 3),51-54.
46. Fink G and Sumner BE (1996) Oestrogen and mental state. Nature 383,306.
47. Garcia-Segura LM, Chowen JA, Duenas M, Torres-Aleman I and Naftolin F (1994) Gonadal steroids as promoters of neuro-glial plasticity. Psychoneuroendocrinology 19,445-453.
48. Garcia-Segura LM, Wozniak A, Azcoitia I, Rodriguez JR, Hutchison RE and Hutchison JB (1999) Aromatase expression by astrocytes after brain injury: Implications for local estrogen formation in brain repair. Neuroscience 89,567-578.
49. Garcia-Segura LM, Azcoitia I and DonCarlos LL (2001) Neuroprotection by estradiol. Prog Neurobiol 63,29-60.
50. Garcia-Segura LM, Veiga S, Sierra A, Melcangi RC and Azcoitia I (2003) Aromatase: A neuroprotective enzyme. Prog Neurobiol 71,31-41.
51. Genazzani AR, Petraglia F, Facchinetti F, Facchini V, Volpe A and Alessandrini G (1984) Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. Am J Obstet Gynecol 149,775-779.
52. Genazzani AR, Petraglia F, Facchinetti F, Grasso A, Alessandrini G and Volpe A (1988) Steroid replacement increase beta-endorphin and beta-lipotropin plasma levels in postmenopausal women. Gynecol Obstet Invest 26,153-159.
53. Genazzani AR, Petraglia F, Mercuri N, Brilli G, Genazzani AD, Bergamaschi M, DeRamundo BM and Volpe A (1990) Effect of steroid hormones and antihormones on hypothalamic beta-endorphin concentrations in intact and castrated female rats. J Endocrinol Invest 13,91-96.
54. Genazzani AR, Palumbo MA, de Micheroux AA, Artini PG, Criscuolo M, Ficarra G, Guo AL, Benelli A, Bertolini A and Petraglia F (1995) Evidence for a role for the neurosteroid allopregnanolone in the modifications of reproductive function in female rats. Eur J Endocrinol 133,375-380.
55. Genazzani AR, Petraglia F and Purdy RH (1996) The Brain: Source and Target for Sex Steroid Hormones. The Parthenon Publishing Group, Italy.
56. Genazzani AR, Lucchesi A, Stomati M, Catarsi S, Genazzani AD, Criscuolo M and Petraglia F (1997) Effects of sex steroid hormones on the neuroendocrine system. Eur J Contracept Reprod Health Care 2,63-69.
57. Genazzani AR, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A, Nappi RE, Luisi S, Palumbo M, Purdy RH et al. (1998) Circulating levels of allopregnanolone in humans: Gender, age and endocrine influences. J Clin Endocrinol Metab 83,2099-2103.
58. Genazzani AR, Bernardi F, Stomati M, Monteleone P, Luisi S, Rubino S, Farzati A, Casarosa E, Luisi M and Petraglia F (2000) Effects of estradiol and raloxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats. Neuroendocrinology 72,162-170.
59. Genazzani AR, Gambacciani M, Simoncini T and Schneider HPG (2003) 'Controversial issues in climacteric medicine' series 3rd 'HRT climacteric and aging brain'. Maturitas 46,7-26.
60. Genazzani AR, Stomati M, Bernardi F, Luisi S, Casarosa E, Puccetti S, Genazzani AD, Palumbo M and Luisi M (2004) Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. Fertil Steril 81(1),757-766.
61. Genazzani AR, Bernardi F, Pluchino N, Begliuomini S, Lenzi E, Casarosa E and Luisi M (2005) Endocrinology of menopausal transition and its brain implications. CNS Spectr 10,449-457.
62. Gould E, Woolley C, Frankfurt M and McEwen BS (1990) Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10,1286-1291.
63. Green PS and Simpkins JW (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18,347-358.
64. Greenfield JP, Leung LW, Cai D, Kaasik K, Gross RS, Rodriguez-Boulan E, Greengard P and Xu H (2002) Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 5,12128-12136.
65. Gruber CJ, Tschugguel W, Schneeberger C and Huber JC (2002) Production and actions of estrogens. N Engl J Med 346,340-352.
66. Haywood SA, Simonian SX, van der Beek EM, Bicknell RJ and Herbison AE (1999) Fluctuating estrogen and progesterone receptor expression in brainstem norepinephrine neurons through the rat estrous cycle. Endocrinology 140,3255-3263.
67. Henderson VW (2000) Hormone Therapy and the Brain. A Clinical Perspective on the Role of Estrogen. The Parthenon Publishing Group, London.
68. Henderson VW, Guthrie JR, Dudley EC, Burger HG and Dennerstein L (2003) Estrogen exposures and memory at midlife. Neurology 60,1369-1371.
69. Herbison AE (1998) Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev 19,302-330.
70. Hernandez-Diaz FJ, Sanchez JJ and Abreu P (2001) Estrogen modulates α1/ β-adrenoceptor-induced signaling and melatonin production in female rat pinealocytes. Neuroendocrinology 73,111-112.
71. Honma K and Wuttke W (1980) Norepinephrine and dopamine turnover rates in the medial preoptic area and the mediobasal hypothalamus of the rat brain after various endocrinological manipulations. Endocrinology 106,1848-1853.
72. Jacobs DM, Tank M-X, Stern Y, Sano M, Marder K, Bell KL, Schofield P, Dooneief G, Gurland B and Mayeux R (1998) Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50,368-373.
73. Jacobson L and Sapolsky R (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12,118-134.
74. Jezierski F and Sohrabji R (2001) Neurotrophin expression in the reproductivity senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging 22,311-321.
75. Kampen DL and Sherwin BB (1994) Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83,979-983.
76. Karla SP (1996) Gonadal steroid hormones promote interactive communication. In Genazzani AR, Petraglia F and Purdy RH (eds) The Brain: Source and Target for Sex Steroid Hormones. The Parthenon Publishing Group, London, pp. 257-276.
77. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD and Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 48,1517-1521.
78. Keefe D, Garcia-Segura LM and Naftolin F (1994) New insights into estrogen action on the brain. Neurobiol Aging 15,495-497.
79. Kelly MJ and Levin ER (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12,152-156.
80. Kelly MJ and Wagner EJ (1999) Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol Metab 10,369-374.
81. Kelly MJ, Lagrange AH, Wagner EJ and Ronnekleiv OK (1999) Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64,64-75.
82. Kruijver FP, Zhou JN, Pool CW, Hofman MA, Gooren LJ and Swaab DF (2000) Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab 85,2034-2041.
83. Kruijver FP, Fernandez-Guasti A, Fodor M, Kraan EM and Swaab DF (2001) Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J Clin Endocrinol Metab 86,818-827.
84. Kuhl DE, Koeppe RA and Minoshima S (1999) In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52,691-699.
85. Kuppers E, Ivanova T, Karolczak M, Lazarov N, Fohr K and Beyer C (2001) Classical and nonclassical estrogen action in the developing midbrain. Horm Behav 40,196-202.
86. Laconi MR, Casteller G and Gargiulo PA (2001) The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats. Eur J Pharmacol 417,111-116.
87. LeBlanc ES, Janowsky J, Chan BK and Nelson HD (2001) Hormone replacement therapy and cognition: Systematic review and meta-analysis. JAMA 285,1489-1499.
88. Lee SJ and McEwen BS (2001) Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41,569-591.
89. Lephart ED, Simpson ER and Trzeciak WH (1991) Rat adrenal 5-alpha-reductase mRNA content and enzyme activity are sex hormone dependent. J Mol Endocrinol 6,163-170.
90. Levin ER (1999) Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab 10,374-377.
91. Lewy AJ and Sack RL (1997) Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: A brief review and critique of the literature. J Biol Rhythms 12,588-594.
92. Linghtman SL, Jacobs HS and Maguire AK (1981) Climateric flushing: clinical and endocrine response to infusion of naloxone. Br J Obstet Gynecol 88,919-924.
93. Luine VN and Rhodes JC (1983) Gonadal hormone regulation of MAO and other enzymes in hypothalamic areas. Neuroendocrinology 36,235-241.
94. Luine V, Park D, Joh T, Reis D and McEwen B (1980) Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Res 191,273-277.
95. MacLennan AH, Henderson VW, Paine BJ, Mathias J, Ramsay EN, Ryan P, Stocks NP and Taylor AW (2006) Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: The REMEMBER pilot study. Menopause 13,28-36.
96. Majewska MD (1992) Neurosteroids: Endogenous bimodal modulators of the GABA A receptors. Mechanism of action and physiological significance. Prog Neurobiol 38,379-395.
97. Maki PM, Zonderman AB and Resnick SM (2001) Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 158,227-233.
98. Maki PM, Pich JB and Rosenbaum S (2002) Implicit memory varies across the menstrual cycle: Estrogen effects in young women. Neuropsychologia 40,518-529.
99. Matthews K, Cauley J, Yaffe K and Zmuda JM (1999) Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 47,518-523.
100. Mattson MP (1992) Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol 27,29-49.
101. Mattson MP, Robinson N and Guo Q (1997) Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 8,3817-3821.
102. McEwen B (2002) Estrogen actions throughout the brain. Recent Prog Horm Res 57,357-384.
103. McEwen BS and Alves SH (1999) Estrogen actions in the central nervous system. Endocr Rev 20,279-307.
104. McEwen BS, Alves SE, Bulloch K and Weiland NG (1997) Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48,8-15.
105. McEwen BS, Akama K, Alves S, Brake WG, Bulloch K, Lee S, Li C, Yuen G and Milner TA (2001) Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci USA 98,7093-7100.
106. McMillan PJ, Singer CA and Dorsa DM (1996) The effects of ovariectomy andestrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J Neurosci 16,1860-1865.
107. Mellon SH (1994) Neurosteroids: Action and clinical relevance. J Clin Endocrinol Metab 78,1003-1008.
108. Meltzer CC, Smith G and DeKosky ST (1998) Serotonin in aging, late-life depression, and Alzheimer's disease: The emerging role of functional imaging. Neuropsychopharmacology 18,407-430.
109. Milewicz A, Bidzinska B, Mikulski E, Demissie M and Tworowska U (2000a) Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels. Gynecol Endocrinol 14,196-203.
110. Milewicz A, Mikulski E and Bidzinska B (2000b) Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus. Int J Obes Relat Metab Disord 24(Suppl 2), S152-S153.
111. Miller KL, Conney JC, Rasgon NL, Fairbanks LA and Small GW (2002) Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 50,1826-1830.
112. Mor G, Nilsen J, Horvath T, Bechmann I, Brown S, Garcia-Segura LM and Naftolin F (1999) Estrogen and microglia: A regulatory system that affects the brain. J Neurobiol 40,484-496.
113. Morioka N, Okatani Y and Wakatsuki A (1999) Melatonin protect against age-related DNA damage in the brains of female senescence-accelerated mice. J Pineal Res 27,202-209.
114. Mufson EJ, Ginsberg SD, Ikonomovic MD and DeKosky ST (2003) Human cholinergic basal forebrain: Chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26,233-242.
115. Nicholson C and Sykova E (1998) Extracellular space structure revealed by diffusion analysis. Trends Neurosci 21,207-215.
116. Nilsen J and Brinton RD (2002) Dual action of estrogen on glutamate-induced calcium signaling: Mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res 930,216-234.
117. Nilsen J and Brinton RD (2003a) Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci USA 100,10506-10511.
118. Nilsen J and Brinton RD (2003b) Mechanism of estrogen mediated neuroprotection: Regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci USA 100,2842-2848.
119. Nilsen J, Mor G and Naftolin F (2000) Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J Neurobiol 43,64-78.
120. Okatani Y, Morioka N and Wakatsuki A (2000) Changes in nocturnal melatonin secretion in perimenopausal women. Correlation with endogenous estrogen concentrations. J Pineal Res 28,111-118.
121. Palumbo MA, Salvestroni C, Gallo R, Guo AL, Genazzani AD, Artini PG, Petraglia F and Genazzani AR (1995) Allopregnanolone concentrations in hippocampus of prepubertal rats and female rats throughout estrous cycle. J Endocrinol Invest 18,853-856.
122. Panay N, Sands RH and Studd JWW (1996) Estrogen and behaviour. In Genazzani AR, Petraglia F and Purdy RH (eds) The Brain: Source and Target for Sex Steroid Hormones. The Parthenon Publishing Group, London, pp. 257-276.
123. Pecins-Thompson M, Brown NA, Kohama SG and Bethea CL (1996) Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci 16,7021-7029.
124. Peterson RS, Saldanha CJ and Schlinger BA (2001) Rapid upregulation of aromatase mRNA and protein following neural injury in the zebra finch (Taeniopygia guttata). J Neuroendocrinol 13,317-323.
125. Pfaff DW (1980) Estrogens and Brain Function. Springer-Verlag, New York.
126. Phillips RG and LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106,274-285.
127. Phillips SM and Sherwin BB (1992a) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17,485-495.
128. Phillips SM and Sherwin BB (1992b) Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 17,497-506.
129. Polcz T, Horvath T and Naftolin F (1998) In Fraser IS, Jansen RPS and Whitehead MJ (eds) Effects of Estrogen and Progesterone on the Central System. Churchill Livingston, Edinburgh.
130. Ramirez VD, Kipp JL and Joe I (2001) Estradiol, in the CNS, targets several physiologically relevant membrane-associated proteins. Brain Res Rev 37,141-152.
131. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J et al. (2003) Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 289,2663-2672.
132. Reiter RJ (1991) Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr Rev 12,151-180.
133. Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56,359-384.
134. Resnick SM, Metter EJ and Zonderman AB (1997) Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect? Neurology 49,1491-1497.
135. Saleh TM and Connell BJ (2003) Estrogen-induced autonomic effects are mediated by NMDA and GABAA receptors in the parabrachial nucleus. Brain Res 973,161-170.
136. Sànchez JJ, Abreu P, González-Hernández T, Hernández A, Prieto L and Alonso R (2004) Estrogen modulation of adrenoceptor responsiveness in the female rat pineal gland: Differential expression of intracellular estrogen receptors. J Pineal Res 37,26-35.
137. Sandstrom NJ and Williams CL (2001) Memory retention is modulated by acute estradiol and progesterone replacement. Behav Neurosci 115,384-393.
138. Sasano H, Takashashi K, Satoh F, Nagura H and Harada N (1988) Aromatase in the human central nervous system. Clin Endocrinol (Oxford) 48,325-329.
139. Scharfman HE and Maclusky NJ (2005) Similarities between actions of estrogen and BDNF in the hippocampus: Coincidence or clue? Trends Neurosci 28,79-85.
140. Schneider LS (2004) Estrogen and dementia: Insights from the Women's Health Initiative Memory Study. JAMA 291,3005-3007.
141. Schumacher M, Coirini H and McEwen BS (1989) Regulation of high affinity GABAA receptors in the dorsal hippocampus by estradiol and progesteron. Brain Res 487,178-184.
142. Schumacher M, Coirini H and Robert F (1999) Genomic and membrane actions of progesterone: Implications for reproductive physiology and behavior. Behav Brain Res 105,37-52.
143. Schumacher M, Akwa Y, Guennoun R, Robert F, Labombarda F, Desarnaud F, Robel P, De N and Baulieu EE (2000) Steroid synthesis and metabolism in the nervous system: Trophic and protective effects. J Neurocytol 29,307-326.
144. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJM, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A et al. (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71,3-29.
145. Schwarz S and Pohl P (1994) Steroids and opioid receptors. J Steroid Biochem Mol Biol 48,391-402.
146. Serra M, Pisu MG and Littera M (2000) Social isolation-induced decreases in both the abundance of neuroactive steroids and GABAA receptor function in rat brain. J Neurochem 75,732-740.
147. Sherwin BB (1997) Estrogen effects on cognition in menopausal women. Neurology 48,S21-S26.
148. Sherwin BB (2003) Estrogen and cognitive functioning in women. Endocr Rev 24,133-151.
149. Sherwin BB (2005) Estrogen and memory in women: How can we reconcile the findings? Horm Behav 47(3),371-375.
150. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD et al. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's HealAh Initiative Memory Study: a randomized controlled trial. JAMA 289,2673-2679.
151. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE et al. (2004) Women's Health Initiative Memory Study conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women's Health Initiative Memory Study. JAMA 291,2947-2958.
152. Silva I, Mor G and Naftolin F (2001) Estrogen and the aging brain. Maturitas 38,95-100.
153. Simerly RB, McCall LD and Watson SJ (1988) Distribution of opioid peptides in the preoptic region: Immunohistochemical evidence for a steroidsensitive enkephalin sexual dimorphism. J Comp Neurol 276,442-459.
154. Simpson ER and Davis SR (2001) Minireview: Aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology 142,4589-4594.
155. Sinchak K, Eckersell C, Quezada V, Norell A and Micevych P (2000) Preproenkephalin mRNA levels are regulated by acute stress and estrogen stimulation. Physiol Behav 69,425-432.
156. Singh M, Meyer EM, Millard WJ and Simpkins JW (1994) Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644,305-312.
157. Stoffel-Wagner B (2001) Neurosteroid metabolism in the human brain. Eur J Endocrinol 145,669-679.
158. Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F and Klingmuller D (1999) Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J Steroid Biochem Mol Biol 70,237-241.
159. Stomati M, Bersi C, Rubino S, Palumbo M, Comitini G, Genazzani AD, Santuz M, Petraglia F, Genazzani AR and Santre M (1997) Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women. Maturitas 28,127-135.
160. Stomati M, Bernardi F, Luisi S, Puccetti S, Casarosa E, Liut M, Quirici B, Pieri M, Genazzani AD, Luisi M and Genazzani AR (2002) Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: Effects on central and peripheral allopregnanolone and beta-endorphin. Maturitas 43,195-206.
161. Studd JWW and Smith RNJ (1994) Estrogen and depression in women. Menopause 1,33-37.
162. Sykova E (2001) Glial diffusion barriers during aging and pathological states. Prog Brain Res 132,339-363.
163. Sykova E, Mazel T, Hasenohrl RU, Harvey AR, Simonova Z, Mulders WH and Huston JP (2002) Learning deficits in aged rats related to decrease in extracellular volume and loss of diffusion anisotropy in hippocampus. Hippocampus 12,269-279.
164. Tang MX, Jacobs D and Stern Y (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348,429-432.
165. Toran-Allerand CD (1996) The estrogen/neurotrophin connection during neural development: Is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci 18,36-48.
166. Wang MD, Wahlström G and Bäckström T (1997) The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J Steroid Biochem Mol Biol 62,299-306.
167. Wang J, Green PS and Simpkins JW (2001) Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem 77,804-811.
168. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE et al. (2003) Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial. JAMA 289,2673-2684.
169. Weill-Engerer S, David JP, Sazdovitch V, Liere P, Eychenne B, Pianos A, Schumacher M, Delacourte A, Baulieu EE and Akwa Y (2002) Neurosteroid quantification in human brain regions: Comparison between Alzheimer's and nondemented patients. J Clin Endocrinol Metab 87,5138-5143.
170. White RJ and Reynolds IJ (1996) Mitochondrial depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure. J Neurosci 16, 5688-5697.
171. Wilson MA (1992) Influences of gender, gonadectomy and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res Bull 29,165-172.
172. Wise PM, Rance N and Barraclough CA (1981) Effects of estradiol and progesterone on catecholamine turnover rates in discrete hypothalamic regions in ovariectomized rats. Endocrinology 108,2186-2193.
173. Wolf OT, Neumenm O and Helhammer DH (1997) Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 82,2236-2363.
174. Wong M, Thompson TL and Moss RL (1996) Nongenomic actions of estrogen in the brain: Physiological significance and cellular mechanisms. Crit Rev Neurobiol 10,189-203.
175. Woolley C and McEwen BS (1992) Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12,2549-2554.
176. Woolley C and McEwen BS (1993) Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 336,293-306.
177. Yaffe K, Lui L-Y, Grady D, Cauley J, Kramer J and Cummings SR (2000) Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 356,708-712.
178. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC and Breitner JCS (2002) Hormone replacement therapy and incidence of
179. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F and Jeanrenaud B (1994) Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43,764-769.
180. Zhdanova IV and Wurtman RJ (1997) Efficacy of melatonin as a sleep-promoting agent. J Biol Rhythms 12,644-650.